U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description
Curator's Comment: Description was created based on several sources, including https://www.drugs.com/monograph/senna.html and http://www.drugbank.ca/drugs/DB11365

Sennosides are hydroxyanthracene glycosides derived from Senna leaves. They have been used as natural, safe time-tested laxatives in traditional as well as modern systems of medicine. Sennosides (Senna) is a medication used to treat constipation and empty the large intestine before surgery. The medication is taken by mouth or via the rectum. It typically begins working in minutes when given by rectum and within twelve hours when given by mouth. It is a weaker laxative than bisacodyl or castor oil. Senna is an FDA-approved nonprescription drug for adults and children ages 2 years and older. It is also used for bowel preparation before colonoscopy and diagnostic imaging.

Originator

Curator's Comment: Senna was first used medicinally by Arabian physicians in the 9th century A.D.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
680.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
SENNA

Approved Use

Relieves occasional constipation (irregularity)

Launch Date

2012
PubMed

PubMed

TitleDatePubMed
Effects of senna and its active compounds rhein and rhein-anthrone on PAF formation by rat colon.
1992 Aug
[Effects of sennosides on cellular electric activities in smooth muscle cells of guinea pig taenia coli].
1993 Sep
[The effects of kampo-formulation and the constituting crude drugs, prescribed for the treatment of peptic ulcer on H,K-ATPase activity].
2001 Feb
Patents

Patents

Sample Use Guides

Adults and children 12 years of age or older - 2 tablets once a day starting dose; 4 tablets twice a day maximal dose; children 6 to under 12 years - 1 tablet once a day starting dose; 2 tablets twice a day maximal dose; each Senna Tablet contains: Sennosides 8.6 mg / Standardized Senna Concentrate
Route of Administration: Oral
In Vitro Use Guide
Sennosides (20 mmol/l) induced spontaneous spike potentials in guinea pig taenia coli.
Substance Class Structurally Diverse
Created
by admin
on Fri Dec 15 16:17:49 GMT 2023
Edited
by admin
on Fri Dec 15 16:17:49 GMT 2023
Source Materials Class ORGANISM
Source Materials Type PLANT
Source Materials Parent
Part FRUIT; LEAF; STEM
Fraction Name ANTIOXIDANT ANTHROQUINONE GLUCOSIDE CALCIUM SALT
Record UNII
3FYP5M0IJX
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
SENNOSIDES
USP   VANDF  
Common Name English
CASSIA ACUTIFOLIA ANTHRAQUINONE GLUCOSIDES CALCIUM SALTS
Common Name English
SENNOSIDE CA
Common Name English
CASSIA SENNA ANTHRAQUINONE GLUCOSIDES CALCIUM SALTS
Common Name English
PARTIALLY PURIFIED COMPLEX OF SENNA ALEXANDRINA ANTHRAQUINONE GLUCOSIDE CALCIUM SALTS
Common Name English
SENNA ACUTIFOLIA ANTHRAQUINONE GLUCOSIDES CALCIUM SALTS
Common Name English
COLONORM
Brand Name English
PURSENNID
Brand Name English
CASSIA ANGUSTIFOLIA ANTHRAQUINONE GLUCOSIDES CALCIUM SALTS
Common Name English
SENNA ALEXANDRINA ANTHRAQUINONE GLUCOSIDES CALCIUM SALTS
Common Name English
SENNOSIDES [VANDF]
Common Name English
NYTILAX
Brand Name English
SENNOSIDES [USP-RS]
Common Name English
SENNA ALEXANDRINA ANTHRAQUINONE GLUCOSIDES INCLUDING SENNOSIDE A CALCIUM, SENNOSIDE B CALCIUM, SENNOSIDE C CALCIUM AND SENNOSIDE D CALCIUM
Common Name English
SENNOSIDES [USP MONOGRAPH]
Common Name English
CASSIA ALEXANDRINA ANTHRAQUINONE GLUCOSIDES CALCIUM SALTS
Common Name English
GLYSENNID
Brand Name English
PURSENNIDE
Brand Name English
Classification Tree Code System Code
WHO-ATC A06AB06
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
DSLD 1162 (Number of products:8)
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
WHO-ATC A06AB56
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
NCI_THESAURUS C29697
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
Code System Code Type Description
FDA UNII
3FYP5M0IJX
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY
DAILYMED
3FYP5M0IJX
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY
DRUG BANK
DB11365
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY
RS_ITEM_NUM
1612007
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY
ChEMBL
CHEMBL2108559
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY
RXCUI
36387
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY RxNorm
NCI_THESAURUS
C29448
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY
EVMPD
SUB40994
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY
DRUG CENTRAL
4307
Created by admin on Fri Dec 15 16:17:49 GMT 2023 , Edited by admin on Fri Dec 15 16:17:49 GMT 2023
PRIMARY
Related Record Type Details
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
ACTIVE MOIETY